Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation

Banerjee, S., Sindberg, G., Wang, F., Meng, J., Sharma, U., Zhang, L., Dauer, P., Chen, C. +3 more·2016·Mucosal Immunology

Cited by (266)

Items 101–200 of 266

  1. Towards a Comprehensive Theory of Non-Cancer Acute and Chronic Pain Management: The Critical Role of Reactive Oxygen and Nitrogen Species in Pain, and Opioid Dependence, Addiction, Hyperalgesia, and Tolerance
    Tobore Onojighofia Tobore · 2021 · Advances in Redox Research
  2. The regulatory effects and mechanisms of plant food-derived bioactive components on gut barrier function and intestinal homeostasis: a comprehensive review
    Peichun Xie, Zeyuan Ma, Xiaoshuang Yang, Huixin Pan, Peiyi Shen, Hengjun Du, Yong Cao, Jie Xiao, Hang Xiao, Mingyue Song · 2025 · Critical Reviews in Food Science and Nutrition
  3. Opioids and Sepsis: Elucidating the Role of the Microbiome and microRNA-146
    Yaa Fosuah Abu, Nicolas Vitari, Yan Yan, Sabita Roy · 2022 · International Journal of Molecular Sciences
  4. Antibiotic Knockdown of Gut Bacteria Sex-Dependently Enhances Intravenous Fentanyl Self-Administration in Adult Sprague Dawley Rats
    Michelle Ren, S. Lotfipour · 2022 · International Journal of Molecular Sciences
  5. Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in rats
    Saadet Inan, Joseph J. Meissler, Shingo Bessho, Sonita Wiah, Çağla Tükel, Toby K. Eisenstein, Scott M. Rawls · 2024 · Brain Behavior and Immunity
  6. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy
    Wei Jiang, Zhenwu Luo, Lisa Martin, Zhuang Wan, Pingfu Fu, Amanda M. Wagner, Binhua Ling, Sonya L. Heath, Azizul Haque, Aimee L. McRae‐Clark · 2018 · Current HIV Research
  7. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis
    Nariman Essmat, Dávid Árpád Karádi, Ferenc Zádor, Kornél P Király, Susanna Fürst, Mahmoud Al‐Khrasani · 2023 · Molecules
  8. Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice
    Namisha Thapa, Matthew Robert Kappus, Ryan T. Hurt, Sarah J. Diamond · 2019 · Current Gastroenterology Reports
  9. Supplementation of multi-enzymes alone or combined with inactivated Lactobacillus benefits growth performance and gut microbiota in broilers fed wheat diets
    Qingtao Gao, Yanchun Wang, Jiaheng Li, Guosong Bai, Lei Liu, Ruqing Zhong, Teng Ma, Hongbin Pan, Hongfu Zhang · 2022 · Frontiers in Microbiology
  10. Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis
    Richa Jalodia, Udhghatri Kolli, Regina Gonzalez Braniff, Junyi Tao, Yaa Fosuah Abu, Irina Chupikova, Shamsudheen Moidunny, Sundaram Ramakrishnan, Sabita Roy · 2022 · Gut Microbes
  11. Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity
    Dawn Jessup, Kareem Woods, Sach Thakker, Mohamad Imad Damaj, Hamid I. Akbarali · 2023 · Scientific Reports
  12. The Microbiome and Mental Health Across the Lifespan
    Faith Dickerson, Amanda Hazel Dilmore, Filipa Godoy‐Vitorino, Tanya T. Nguyen, Martin P. Paulus, Adrian A. Pinto‐Tomás, Cristofer Moya-Roman, Ibrahim Zúñiga-Chaves, Emily G. Severance, Dilip V. Jeste · 2022 · Current topics in behavioral neurosciences
  13. Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities
    Yujiang Xi, Zhifeng Wang, Yuanyuan Wei, Niqin Xiao, Li Duan, Ting Zhao, Xiaoyu Zhang, Liping Zhang, Jian Wang, Zhaofu Li et al. · 2025 · The American Journal of Chinese Medicine
  14. Decreased Intestinal Microbiota Diversity Is Associated With Increased Gastrointestinal Symptoms in Patients With Chronic Pancreatitis
    Kendall R. McEachron, Harika Nalluri, Gregory J. Beilman, Varvara A. Kirchner, Timothy L. Pruett, Martin L. Freeman, Guru Trikudanathan, Christopher M. Staley, Melena D. Bellin · 2022 · Pancreas
  15. Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration?
    Elisabetta Gerace, Simone Baldi, Maya Salimova, Leandro Di Gloria, Lavinia Curini, Virginia Cimino, Giulia Nannini, Edda Russo, Marco Pallecchi, Matteo Ramazzotti et al. · 2023 · iScience
  16. The Gut-Brain Axis in Opioid Use Disorder: Exploring the Bidirectional Influence of Opioids and the Gut Microbiome—A Comprehensive Review
    Artūras Barkus, Vaida Baltrūnienė, Justė Baušienė, Tomas Baltrūnas, Lina Barkienė, Paulina Kazlauskaitė, Augustinas Baušys · 2024 · Life
  17. Neonatal Morphine Results in Long-Lasting Alterations to the Gut Microbiome in Adolescence and Adulthood in a Murine Model
    Danielle Antoine, Praveen Kumar Singh, Junyi Tao, Sabita Roy · 2022 · Pharmaceutics
  18. The Central Role of Gut Microbiota in Drug Metabolism and Personalized Medicine
    Gianni Colotti, Teresa Rinaldi · 2020 · Future Medicinal Chemistry
  19. Ketogenic diet: a potential adjunctive treatment for substance use disorders
    Deshenyue Kong, Jiaxue Sun, Ji-qun Yang, Yuan-sen Li, Ke Bi, Zunyue Zhang, Kunhua Wang, Hua-you Luo, Mei J. Zhu, Yu Xu · 2023 · Frontiers in Nutrition
  20. Regulation of Pain Perception by Microbiota in Parkinson Disease
    Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco · 2023 · Pharmacological Reviews
  21. Effect of Opioid Use on Immune Activation and HIV Persistence on ART
    Livio Azzoni, David S. Metzger, Luis J. Montaner · 2020 · Journal of Neuroimmune Pharmacology
  22. The role of gut-immune-brain signaling in substance use disorders
    Kelsey E. Lucerne, Drew D. Kiraly · 2020 · International review of neurobiology
  23. Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier
    Xiao Li, Lilin Hu, Huikuan Chu, Liuying Chen, Jingjing Yan, Weijun Wang, Xiaoqian Yang, Qingjing Zhu, Fan Du, Yuhu Song et al. · 2022 · Journal of Clinical and Translational Hepatology
  24. Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators
    Samantha M. Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, Cheryl L. Limebeer, Erin M. Rock, Reem Smoum, Mathew Farag, Hannah de Almeida, Megan T. Sullivan, Sébastien Lacroix et al. · 2021 · Frontiers in Pharmacology
  25. Morphine and high-fat diet differentially alter the gut microbiota composition and metabolic function in lean versus obese mice
    J. Alfredo Blakeley‐Ruiz, Carlee S. McClintock, Him K. Shrestha, Suresh Poudel, Zamin Koo Yang, Richard J. Giannone, James J. Choo, Mircea Podar, Helen A. Baghdoyan, Ralph Lydic et al. · 2022 · ISME Communications
  26. The gut microbiome contributes to somatic morphine withdrawal behavior and implicates a TLR2 mediated mechanism
    Bridget Truitt, Greeshma Venigalla, Praveen Singh, Salma Singh, Junyi Tao, Irina Chupikova, Sabita Roy · 2023 · Gut Microbes
  27. Understanding the impact of the gut microbiome on opioid use disorder: Pathways, mechanisms, and treatment insights
    Negin Kazemian, Sepideh Pakpour · 2024 · Microbial Biotechnology
  28. The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis
    Marina Kleopatra Boziki, Nikolaos Grigoriadis, Apostolis Papaefthymiou, Michael Doulberis, Stergios A. Pοlyzos, Emmanuel Gavalas, Georgia Deretzi, Eleni Karafoulidou, Evangelia Kesidou, Charilaos Taloumtzis et al. · 2021 · Neurochemistry International
  29. A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide‐receptor interaction
    Xubiao Wei, Lulu Zhang, Rijun Zhang, Rujuan Wu, Dayong Si, Baseer Ahmad, James N. Petitte, Paul Edward Mozdziak, Zhongxuan Li, Henan Guo et al. · 2020 · The FASEB Journal
  30. Morphine use induces gastric microbial dysbiosis driving gastric inflammation through TLR2 signalling which is attenuated by proton pump inhibition
    Nillu Ghosh, Kousik Kesh, Praveen Kumar Singh, Umakant Sharma, Irina Chupikova, Sundaram Ramakrishnan, Sabita Roy · 2022 · British Journal of Pharmacology
  31. Research trends in the field of the gut-brain interaction: Functional dyspepsia in the spotlight – An integrated bibliometric and science mapping approach
    Tai Zhang, Beihua Zhang, Xiangxue Ma, Jiaqi Zhang, Yuchen Wei, Fengyun Wang, Xudong Tang · 2023 · Frontiers in Neuroscience
  32. Evolutionary modeling suggests that addictions may be driven by competition-induced microbiome dysbiosis
    Ohad Lewin‐Epstein, Yanabah Jaques, Marcus W. Feldman, Daniela Kaufer, Lilach Hadany · 2023 · Communications Biology
  33. Reproducible microbiome composition signatures of anxiety and depressive symptoms
    Afroditi Kouraki, Anthony Kelly, Amrita Vijay, Sameer Akram Gohir, Stuart Astbury, Vasileios Georgopoulos, Bonnie Millar, David Andrew Walsh, Eamonn Ferguson, Cristina Menni et al. · 2023 · Computational and Structural Biotechnology Journal
  34. Probiotics in Postoperative Pain Management
    Barbara Fyntanidou, Aikaterini Amaniti, Eleftheria Soulioti, Sofia–Chrysovalantou Zagalioti, Sofia Gkarmiri, Angeliki G. Chorti, Lamprini Loukipoudi, Aris Ioannidis, Ioannis Dalakakis, Alexandra-Eleftheria Menni et al. · 2023 · Journal of Personalized Medicine
  35. Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Philip M. Young, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D. Gentzler, Linda W. Martin, Wendy M. Novicoff, Richard Delmar Hall · 2024 · Current Oncology
  36. Dietary Methionine Restriction Improves Gut Health and Alters the Plasma Metabolomic Profile in Rats by Modulating the Composition of the Gut Microbiota
    Mei Yang, Qian Xie, Yintao Xiao, Minglong Xia, Jiashun Chen, Bie Tan, Yulong Yin · 2024 · International Journal of Molecular Sciences
  37. Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
    Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. A. Pradhan, Ream Al‐Hasani · 2020 · Molecular Pharmacology
  38. Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: Microbial-immune-metabolic network
    Yuanhao Sun, Xiao-Gang Dong, Yi Chen, Jian-jun Han, Wenjia Guo · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  39. Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies
    Jeffrey J Bettinger, Bruce C. Friedman · 2024 · Palliative Medicine Reports
  40. Opioid Use and Gut Dysbiosis in Cancer Pain Patients
    Flaminia Coluzzi, Maria Sole Scerpa, Chiara Loffredo, Marina Borro, Joseph V. Pergolizzi, Jo Ann LeQuang, Elisa Alessandri, Maurizio Simmaco, Monica Rocco · 2024 · International Journal of Molecular Sciences
  41. Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents
    Yiran Wang, Zhiheng Wu, Xudong Zhu, Yu Zheng, Yanyan Yang, Jinming Tu, Hongming Pan, Xian Zhong, Weidong Han, Junlin Yao · 2024 · Journal of Gastrointestinal Cancer
  42. Gut microbiota alterations may increase the risk of prescription opioid use, but not vice versa: A two-sample bi-directional Mendelian randomization study
    Liling Lin, Jianwei Lin, Junxiong Qiu, Wei Feng, Xiaohui Bai, Weiying Ma, Jingxian Zeng, Daowei Lin · 2022 · Frontiers in Microbiology
  43. Opioid Use and Rate of Nicotine Metabolism Among Pregnant Smokers
    Cheryl A. Oncken, Erin L. Mead, Ellen A. Dornelas, Chia‐Ling Kuo, Heather Z. Sankey, Henry R. Kranzler, Sheila Thurlow · 2019 · Nicotine & Tobacco Research
  44. Prescription opioids induced microbial dysbiosis worsens severity of chronic pancreatitis and drives pain hypersensitivity
    Kousik Kesh, Junyi Tao, Nillu Ghosh, Richa Jalodia, Salma Singh, Rajinder Kumar Dawra, Sabita Roy · 2024 · Gut Microbes
  45. The interplay between the microbiota and opioid in the treatment of neuropathic pain
    Zexiong Gong, Qingsheng Xue, Yan Luo, Buwei Yu, Bo Hua, Zhiheng Liu · 2024 · Frontiers in Microbiology
  46. The “Culture” of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance
    Ryan A. Mischel, Karan H. Muchhala, William L. Dewey, Hamid I. Akbarali · 2019 · Journal of Pain
  47. The effect of prescribing antibiotics with opioids on the development of opioid use disorder: a national database study
    Zachary G. Freedman, Jennifer A. Kane, Tonya Sharp King, Nicholas Graziane · 2021 · Journal of Addictive Diseases
  48. The future of neuroimaging and gut-brain axis research for substance use disorders
    Luis M. Colón-Pérez, Johanna S. Montesinos, Mildred Monsivais · 2022 · Brain Research
  49. Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection
    Livio Azzoni, Leila B. Giron, Surya Kumari Vadrevu, Ling Zhao, Linden Lalley-Chareczko, Emily Hiserodt, Matthew G. Fair, Kenneth Lynn, Stacey B. Trooskin, Karam Mounzer et al. · 2022 · Journal of Leukocyte Biology
  50. The Gut Microbiota-Brain Axis: Potential Mechanism of Drug Addiction
    Xiao Luo, Hong Li, Xuan Fan, Xiaocong Wu, Rui-Yi Zhou, Yi Lei, Dan Xue, Fazheng Yang, Yu Xu, Kunhua Wang · 2023 · Current Topics in Medicinal Chemistry
  51. From dysmotility to virulent pathogens: implications of opioid use in the ICU
    Lee‐anne S. Chapple, Adam M. Deane · 2018 · Current Opinion in Critical Care
  52. Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs
    Mattia Trunfio, Antoine Chaillon, Nadejda Beliakova‐Bethell, Robert Deiss, Scott Lee Letendre, Patricia K. Riggs, Niamh M. Higgins, Sara Gianella · 2023 · Viruses
  53. The Impact of Drugs and Substance Abuse on Viral Pathogenesis—A South African Perspective
    Lufuno Ratshisusu, Omphile E. Simani, Jason T. Blackard, Selokela G. Selabe · 2024 · Viruses
  54. Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic morphine
    Izabella Sall, Randi L. Foxall, Lindsey C. Felth, Soren Maret, Zachary Rosa, Anirudh Gaur, Jennifer Calawa, Nadia Pavlik, Jennifer Lynne Whistler, Cheryl A. Whistler · 2025 · Gut Microbes
  55. Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors
    Bridget Herlihy, Sabita Roy · 2022 · Advances in Drug and Alcohol Research
  56. Increased LPS-Induced Fever and Sickness Behavior in Adult Male and Female Rats Perinatally Exposed to Morphine
    Hannah J. Harder, Morgan G. Gomez, Christopher T. Searles, Meghan E Vogt, Anne Z. Murphy · 2023 · Brain Behavior and Immunity
  57. Single-Cell RNA Transcriptomics and Multi-omics Analyses Reveal the Clinical Effects of Acupuncture on Methadone Reduction
    Yi‐Ming Chen, Baochao Fan, Jingchun Zeng, Yutian Zou, Chenyang Tao, Chen Chen, Peiming Zhang, Jian Liang, Fangfang Qi, Hailin Tang et al. · 2025 · Research
  58. Chronic Morphine Induces IL-18 in Ileum Myenteric Plexus Neurons Through Mu-opioid Receptor Activation in Cholinergic and VIPergic Neurons
    Karan H. Muchhala, Eda Köşeli, Aravind R. Gade, Kareem Woods, Suha Minai, Minho Kang, A. Rory McQuiston, William L. Dewey, Hamid I. Akbarali · 2022 · Journal of Neuroimmune Pharmacology
  59. HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
    Sanjana Satish, Yaa Fosuah Abu, Daniel Richard Gomez, Rajib Kumar Dutta, Sabita Roy · 2023 · Frontiers in Immunology
  60. The role of the gut microbiome and microbial metabolism in mediating opioid-induced changes in the epigenome
    Udhghatri Kolli, Sabita Roy · 2023 · Frontiers in Microbiology
  61. Long access heroin self-administration significantly alters gut microbiome composition and structure
    Jonathan M. Greenberg, Andrew D. Winters, Branislava Zagorac, David J. Kracht, Dina M. Francescutti, Nazzareno Cannella, Roberto Ciccocioppo, Leah C. Solberg Woods, James Mackle, Gary Hardiman et al. · 2024 · Frontiers in Psychiatry
  62. The bidirectional relationship between opioids and the gut microbiome: Implications for opioid tolerance and clinical interventions
    Zahra Salem Taboun, Javad Sadeghi · 2023 · International Immunopharmacology
  63. Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
    Luigi Liguori, Gabriele Giorgio, Giovanna Polcaro, Valentina Pagliara, Domenico Malandrino, Francesco Perri, Marco Cascella, Alessandro Ottaiano, Valeria Conti, Alberto Servetto et al. · 2024 · Frontiers in Immunology
  64. Neonatal exposure to morphine results in prolonged pain hypersensitivity during adolescence, driven by gut microbial dysbiosis and gut-brain axis-mediated inflammation
    Danielle Antoine, Junyi Tao, Salma Singh, Praveen Kumar Singh, Barbara G Marin, Sabita Roy · 2025 · Brain Behavior and Immunity
  65. The self-serving benefits of being a good host: A role for our micro-inhabitants in shaping opioids’ function
    Shoshana Eitan, Caitlin A. Madison, Jacob Kuempel · 2021 · Neuroscience & Biobehavioral Reviews
  66. Morphine Exacerbates Experimental Colitis-Induced Depression of Nesting in Mice
    Stanley M. Cheatham, Karan H. Muchhala, Eda Köşeli, Joanna C. Jacob, Essie Komla, S. Stevens Negus, Hamid I. Akbarali · 2021 · Frontiers in Pain Research
  67. Chronic Morphine Treatment and Antiretroviral Therapy Exacerbate HIV-Distal Sensory Peripheral Neuropathy and Induce Distinct Microbial Alterations in the HIV Tg26 Mouse Model
    Irina Chupikova, Danielle Antoine, Richa Jalodia, Praveen Kumar Singh, Sabita Roy · 2024 · International Journal of Molecular Sciences
  68. Genetically supported causality between gut microbiota, immune cells and morphine tolerance: a two-sample Mendelian randomization study
    Shuai Han, Jiapei Gao, Zi Wang, Yinggang Xiao, Yali Ge, Yongxin Liang, Ju Gao · 2024 · Frontiers in Microbiology
  69. Antibiotic treatment improves gut dysbiosis and depression-like behavior induced by morphine withdrawal
    Dong-yu Yu, Jing-qi Gao, Xi-xi Yang, Fei-fei Gao, Junlin Liu, Meng-qing Shen, Bin Gu, Yu-xiang Zhang, Chunxia Yan · 2025 · Neuropharmacology
  70. Multiple reports on the causal relationship between various chronic pain and gut microbiota: a two-sample Mendelian randomization study
    Yuxin Cai, Shuyang Wen, Jinjing Hu, Ziyi Wang, Guozhi Huang, Qing Zeng, Jihua Zou · 2024 · Frontiers in Neuroscience
  71. Correlation between postmortem microbial signatures and substance abuse disorders
    Gulnaz T. Javan, Tiara Wells, Jamese Allen, Silvia Damiana Visoná, Matteo Moretti, Craig D. Tipton, Latia Scott, Sheree J. Finley · 2022 · PLoS ONE
  72. Host miR-129-5p reverses effects of ginsenoside Rg1 on morphine reward possibly mediated by changes in B. vulgatus and serotonin metabolism in hippocampus
    Chan Li, Yingbo Lin, Rukun Lin, Zhijie Chen, Qichun Zhou, Chaohua Luo, Zhixian Mo · 2023 · Gut Microbes
  73. The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review
    Jixin Chen, Shuqi Chen, Hui Luo, Shunqin Long, Xiaobing Yang, Wenfeng He, Wanyin Wu, Sumei Wang · 2023 · International Immunopharmacology
  74. Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell‐derived secretome in preclinical models of morphine dependence
    Mauricio Quezada, Carolina A. Ponce, Pablo Berríos‐Cárcamo, Daniela Santapau, Javiera Gallardo, Cristian De Gregorio, Marı́a Elena Quintanilla, Paola Morales, Marcelo Ezquer, Mario Herrera‐Marschitz et al. · 2023 · CNS Neuroscience & Therapeutics
  75. Ketamine induced gut microbiota dysbiosis and barrier and hippocampal dysfunction in rats
    Lei Xie, Zelin Zhuang, Baowen Guo, Yuehua Huang, Xiaoyan Shi, Zikai Huang, Ziquan Xu, Yanbin Chen, Yuyin Cao, Yanmin Zheng et al. · 2024 · iScience
  76. The Effect of Fentanyl Abuse on the Gut Microbiota Pattern, Inflammation, and Metabolic Alterations in a Fentanyl Dependance Rat Model
    Kianoosh Ferdosnejad, Parvaneh Maghami, Mohammad‐Reza Zarrindast, Seyed Davar Siadat · 2025 · Mediators of Inflammation
  77. Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?
    Giovanni Tarantino, Mauro Cataldi, Vincenzo Citro · 2024 · Frontiers in Microbiology
  78. Physical Exercise Repairs Obstructive Jaundice-Induced Damage to Intestinal Mucosal Barrier Function via H2S-Mediated Regulation of the HMGB1/Toll Like Receptors 4/Nuclear Factor Kappa B Pathway
    Changfeng Shao, Ye Li, Jiaqin Chen, Lan Zheng, Wei Chen, Qi Peng, Rui Chen, Afang Yuan · 2022 · Frontiers in Physiology
  79. Systems biology analyses reveal enhanced chronic morphine distortion of gut-brain interrelationships in simian human immunodeficiency virus infected rhesus macaques
    Omalla Allan Olwenyi, Samuel D. Johnson, Mehdi R. M. Bidokhti, Vandana Thakur, Kabita Pandey, Michellie Thurman, Arpan Acharya, Srijayaprakash Babu Uppada, Shannon E. Callen, Luis David Giavedoni et al. · 2022 · Frontiers in Neuroscience
  80. Progress in the study of intestinal microbiota involved in morphine tolerance
    Ke Bi, Yi Lei, Deshenyue Kong, Yuansen Li, Xuan Fan, Xiao Luo, Ji-Qun Yang, Guangqing Wang, Xuejun Li, Yu Xu et al. · 2024 · Heliyon
  81. Genetic association of gut microbiota with osteoarthritis: a multivariable Mendelian randomization study considering medication use
    Ming-Hui Huang, Caixia Liu, Yisheng Huang, Tingyu He, Ziqiang Dong · 2024 · Journal of Medical Microbiology
  82. Phase-dependent hepatotoxicity of Aluminum oxide nanoparticles mediated through the intestinal microbiota
    Mingshu Li, Fuchang Deng, Li Dong, Xiaona Wang, Haiyan Jiang, Siyu Yao, Yuanyuan Chen, Lian Duan, Huamao Du, Guangqiu Qin et al. · 2025 · Environment International
  83. Progresses in Questing for the Truth of Opioid‐Related Constipation in Cancer Patients
    Mengxue Liu, Yedong Sheng, Yifan He, Shixiang Wu, Chunhui Jin, Lijuan Shen · 2025 · Journal of Cellular and Molecular Medicine
  84. Mending the divide: integrating opioid analgesia and immunotherapy for optimal cancer care
    Celia R. DeJohn, Emese Zsíros · 2025 · Journal for ImmunoTherapy of Cancer
  85. The influence of intestinal microbiome on wound healing and infection
    Monika A. Krezalek, John C. Alverdy · 2017 · Seminars in Colon and Rectal Surgery
  86. Opioid Use and Morbidities during Left Ventricular Assist Device Support
    Pamela S. Combs, Teruhiko Imamura, Umar A. Siddiqi, Saeid Mirzai, Robert E. Spiller, Corinne Stonebraker, C. LaBuhn, Heather M. Bullard, Pamela B. Simone, Valluvan Jeevanandam · 2020 · International Heart Journal
  87. Role of microbiota in pain: From bench to bedside
    Huiguang Ren, Bo Cao, Qixuan Xu, Ruiyang Zhao, Hanghang Li, Bo Wei · 2025 · iMetaOmics.
  88. Morphine-induced intestinal microbial dysbiosis drives TLR-dependent IgA targeting of gram-positive bacteria and upregulation of CD11b and TLR2 on a sub-population of IgA + B cells
    Nicolas Vitari, Salma Singh, Junyi Tao, Bridget Truitt, Udhghatri Kolli, Richa Jalodia, Kathryn M LaPorte, Yaa Fosuah Abu, Danielle Antoine, Umakant Sharma et al. · 2024 · Gut Microbes
  89. Longitudinal and Concurrent Changes in Brain and Gut due to Morphine Self‐Administration
    Kaylee Brunetti, Zicong Zhou, Samia Shuchi, Raymond Berry, Sabrina White, Yan Zhang, Michael S. Allen, Shao‐Hua Yang, Johnny D. Figueroa, Luis M. Colón-Pérez · 2025 · Addiction Biology
  90. Perinatal Morphine Exposure Induces Long-Term Changes in the Intestinal Microbiota of Male and Female Rats
    Hannah J. Harder, Charlène J. G. Dauriat, Benoît Chassaing, Anne Z. Murphy · 2023 · Brain Behavior and Immunity
  91. Microbiome‐derived metabolites in substance use disorders: Mechanisms and implications
    Marta Koperska, Drew D. Kiraly · 2025 · Annals of the New York Academy of Sciences
  92. Worldwide Research Trends on Substance Use Disorder‐Related Inflammatory Imbalances: A Bibliometric Analysis
    Shirui Cao, Longtao Yang, Ruixin Wang, Jun Liu · 2025 · CNS Neuroscience & Therapeutics
  93. Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors
    Gözde Kavgacı, Deniz Can Güven, Yunus Kaygusuz, Ece Karaca, Ömer Dızdar, Saadettin Kılıçkap, Sercan Aksoy, Mustafa Erman, Şuayib Yalçın · 2024 · Supportive Care in Cancer
  94. Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats
    Bethany Crouse, Li Zhang, Christine Robinson, Yuguang J. Ban, Jennifer R. Vigliaturo, Sabita Roy, Marco Pravetoni · 2021 · Human Vaccines & Immunotherapeutics
  95. Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome
    Shadab Forouzan, Keely McGrew, Therese A. Kosten · 2021 · American Journal on Addictions
  96. Gut microbial dysbiosis in individuals with Sjögren’s disease
    Roberto Méndez, Arjun Watane, Monika Farhangi, Kara M. Cavuoto, Tom Leith, Shrish Budree, Anat Galor, Santanu Banerjee · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Bifidobacterium pseudolongum attenuates morphine tolerance via TLR4 in a male mouse model of bone cancer pain
    Wei Cao, Yufei Shi, Manyu Xing, Shuang Liang, Jiajia Dai, Zhengyiqi Li, Zhuofeng Ding, Wangyuan Zou · 2025 · Neuropharmacology
  98. The temporal relationship between antibiotic and opioid prescription on the risk of developing an opioid use disorder: A national database study
    Peter Shafeek, Taylor J. Clegg, Noor Kawmi, Sierra Luciano, Curtis Bone, Nicholas Graziane · 2022 · Journal of Addictive Diseases
  99. Opioids and the Immune System
    Claudia González‐Espinosa, Iris Karina Madera-Salcedo, Luz M. Molina-Martínez, Frida L. Martínez-Cuevas · 2022 · Springer eBooks
  100. Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome
    Eamonn P. Duffy, Ryan K. Bachtell, Marissa A. Ehringer · 2023 · Neuroscience & Biobehavioral Reviews